BSc (Hons), MBChB, MRCP, MSc, DPhil, FFPH
Clinical Research Fellow
Fiona Bragg is a Clinical Research Fellow based in the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU).
Fiona studied medicine at the University of St Andrews and the University of Manchester, and trained initially in general medicine. Following this, she undertook specialist training in public health in London, during which time she obtained an MSc in Public Health from the London School of Hygiene and Tropical Medicine, a DPhil in Population Health from the Nuffield Department of Population Health, and Fellowship of the Faculty of Public Health.
After completing her public health specialist training in 2016, Fiona returned to CTSU to work mainly on the China Kadoorie Biobank (CKB) study, where her research focuses on the epidemiology of diabetes, including using genomic and metabolomic approaches to gain an understanding of the determinants and consequences, in particular vascular consequences, of diabetes. She currently holds a Transition Research Fellowship from the BHF Centre of Research Excellence, Oxford, for research into the role of diabetes, and of glycaemia more generally, in atherosclerotic cardiovascular diseases within the CKB. Fiona is module co-lead for the Non-Communicable Diseases module of the MSc in Global Health Science and teaches epidemiology on the medical student public health course. She is also an Honorary Clinical Research Fellow at the Oxford Centre for Diabetes, Endocrinology and Metabolism.
Young adulthood and adulthood adiposity in relation to incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis.
Pang Y. et al, (2017), J Epidemiol Community Health
Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies.
Pang Y. et al, (2017), Int J Cancer, 140, 1781 - 1788
Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
Bragg F. et al, (2017), JAMA, 317, 280 - 289
Extreme ischaemic heart disease risk in people with type 1 diabetes
Herrington W. and Bragg F., Heart